Opportunity Snapshot
- Country: India
- Industry: Medical, Health Care, Pharmaceutical
- Stage: Initial growth (first revenues)
- Years in operations: 3
- Investment size: $1,000,000 / min. $500,000
- Type of investment: Debt, Equity
Investment Opportunity
Funding will be used to sustain and expand exports and to build manufacturing facility to have better control of supply chain & logistics and increase profit.
Pharmaceutical manufacturer of fast moving tablets, capsules and syrups focused on emerging markets specifically Asia and Africa seeks equity and/or debt funding to expand operations and to build a ultra-modern WHO GMP compliant pharmaceutical formulation facility.
We are a professionally managed pharmaceutical private limited company in India. The company is in its 3rd year of operation and expects to have a good year from domestic sales and exports to Asia and Africa. The company management has over 5 decades of experience in pharmaceutical and bio pharmaceutical sales, marketing, manufacturing, regulatory affairs in emerging and regulated markets. One of the key company directors is a U.S. based American Citizen (of Indian Origin).
Rationale for the deal
The company is actively selling in the Indian Market and now wishes to expand to Asia and Africa. Products are in advanced stages of registration and/or approval in a few Asian Countries. The company expects to generate significant revenue and profits from exporting to one particular country where it has excellent foothold and experience.
Use of financing
Funding will be used to sustain and expand exports and to build manufacturing facility to have better control of supply chain & logistics and increase profit.
Opportunity for the investor
Both debt and equity investments will be considered. We will provide more detailed information to interested investors.
Looking for similar investment opportunities